Formulary Management of Targeted Immune Modulators for Ulcerative Colitis

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) characterised by chronic, flaring inflammation and ulcers in the colon. With UC being a lifelong disease, management can become complex and may require multiple drugs in sequence. As a result of recent evidence and detailed analyses, and as the choices for agents used to manage UC expands, so does uncertainty regarding the optimal treatment options and the sequence of drugs that should be used for moderate to severe UC. A class-based review of drugs for UC may enhance cost-effectiveness of pharmacological management of the condition while maximizing outcomes for the patients.

Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.

The “Projects in Progress” page on the CADTH website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.